Prosemble

Prosemble develops advanced cancer treatments by integrating proprietary protein-based nanoparticle delivery systems with artificial intelligence. This technology enables disease-specific targeting and precise drug loading to enhance therapeutic efficacy in oncology. The platform aims to improve treatment outcomes while significantly reducing the systemic side effects associated with conventional chemotherapy.

Traction –/10

London, United Kingdom · HQ

5100+ followers

Artificial Intelligence
Biotechnology
Healthcare Technology

Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Inna Zhuranskaya

CFO/CIO

Product

Features

Prosemble develops advanced cancer treatments by integrating proprietary protein-based nanoparticle delivery systems with artificial intelligence. This technology enables disease-specific targeting and precise drug loading to enhance therapeutic efficacy in oncology. The platform aims to improve treatment outcomes while significantly reducing the systemic side effects associated with conventional chemotherapy.